Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SUMATRIPTAN for Psoriasis: Side Effects & Safety Data

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

There are 19 adverse event reports in the FDA FAERS database where SUMATRIPTAN was used for Psoriasis.

Most Reported Side Effects for SUMATRIPTAN

Side Effect Reports % Deaths Hosp.
Drug ineffective 2,941 16.9% 4 158
Product physical issue 2,349 13.5% 0 10
Application site erythema 1,875 10.8% 0 5
Drug dose omission 1,711 9.8% 0 12
Product quality issue 1,269 7.3% 0 17
Application site pain 1,217 7.0% 0 3
Migraine 978 5.6% 1 144
Headache 914 5.2% 3 159
Product complaint 718 4.1% 0 6
Nausea 702 4.0% 0 93
Product dose omission issue 698 4.0% 0 5
Application site discolouration 684 3.9% 0 2
Application site pruritus 675 3.9% 0 2
Application site burn 629 3.6% 0 1
Drug hypersensitivity 628 3.6% 0 19

Other Indications for SUMATRIPTAN

Migraine (8,854) Product used for unknown indication (4,085) Headache (1,020) Cluster headache (302) Migraine with aura (114) Migraine without aura (92) Ill-defined disorder (73) Pain (48) Migraine prophylaxis (39) Adverse drug reaction (28)

Other Drugs Used for Psoriasis

APREMILAST (76,127) SECUKINUMAB (58,471) ADALIMUMAB (56,634) RISANKIZUMAB-RZAA (40,890) ETANERCEPT (30,483) USTEKINUMAB (21,763) IXEKIZUMAB (16,569) GUSELKUMAB (11,736) CERTOLIZUMAB PEGOL (8,179) METHOTREXATE (6,628)

Related Pages

SUMATRIPTAN Full Profile All Psoriasis Drugs SUMATRIPTAN Demographics SUMATRIPTAN Timeline